Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-01-16 @ 5:41 PM
Study NCT ID:
NCT02734693
Status:
COMPLETED
Last Update Posted:
2020-03-27
First Post:
2016-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Sponsor:
Sumitomo Pharma America, Inc.
Organization: